Brown, Lisle/Cummings’s Haleon HLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.93K Hold
393
﹤0.01% 717
2025
Q4
$3.97K Hold
393
﹤0.01% 575
2025
Q3
$3.52K Hold
393
﹤0.01% 599
2025
Q2
$4.08K Hold
393
﹤0.01% 585
2025
Q1
$4.04K Buy
393
+93
+31% +$915 ﹤0.01% 574
2024
Q4
$2.86K Hold
300
﹤0.01% 581
2024
Q3
$3.17K Buy
+300
New +$2.9K ﹤0.01% 552
2023
Q4
Sell
-294
Closed -$2.45K 574
2023
Q3
$2.45K Sell
294
-99
-25% -$824 ﹤0.01% 504
2023
Q2
$3.29K Sell
393
-3,267
-89% -$27.9K ﹤0.01% 500
2023
Q1
$29.8K Sell
3,660
-5,896
-62% -$47K 0.02% 302
2022
Q4
$76.4K Sell
9,556
-141
-1% -$959 0.04% 232
2022
Q3
$59.1K Buy
+9,697
New +$62.8K 0.03% 241

Other funds holding HLN

Brown, Lisle/Cummings's HLN Position: Q1 2026 in Review

Brown, Lisle/Cummings held its Haleon (HLN) position steady in Q1 2026 at 393 shares worth $3.93K. The position accounts for ﹤0.01% of the portfolio, ranked #717.

Brown, Lisle/Cummings first reported a position in HLN in Q3 2022 and has held it in 12 quarters since. The position peaked at $76.4K in Q4 2022. 625 funds tracked by Wall St. Rank hold HLN as of Q1 2026.

  • Brown, Lisle/Cummings held 393 shares of Haleon worth $3.93K as of Q1 2026.
  • Brown, Lisle/Cummings left its Haleon share count unchanged in Q1 2026.
  • Haleon made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #717 holding.
  • Brown, Lisle/Cummings first reported a position in Haleon in Q3 2022 and has held it in 12 quarters since.
  • Brown, Lisle/Cummings's Haleon position peaked at $76.4K in Q4 2022.
  • 625 funds tracked by Wall St. Rank held Haleon as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.